Reforming the Swedish pharmaceuticals market: consequences for costs per defined daily dose
Crossref DOI link: https://doi.org/10.1007/s10754-016-9186-4
Published Online: 2016-02-08
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bergman, Mats A.
Granlund, David
Rudholm, Niklas
Funding for this research was provided by:
Swedish Competition Authority (KKV 307/2012)
Text and Data Mining valid from 2016-02-08